carbonthatcarbonthat
← Every company

AngioDynamics Inc Insider Trading

Every director, officer and 10% holder of AngioDynamics Inc has to report each trade in its stock within two business days of making it. This is those filings.

ANGO on carbonthat →
Insiders filing
13
51 reported lines
Open-market buys
0
Open-market sales
1
$344K
Net
$344K
sold more

Purchases and sales

Open-market trades only — the lines where someone chose to buy or sell at the going price.

InsiderActionValue
Warren Nighan JRSVP Quality and Regulatory2026-07-3023.4K shat $14.72
Sale
$344K

Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.

More on ANGO

Company overviewEverything on ANGO in one place, with the price.SEC filingsWhat ANGO's 8-Ks say happened: results, departures, auditor changes.Executive payWhat ANGO awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in ANGO.Funds holding itWhich funds and ETFs hold ANGO, and how big a bet.Federal contractsWhat federal agencies pay ANGO.PatentsWhat ANGO is filing at the patent office.

Follow AngioDynamics Inc (ANGO) by email

New trades in AngioDynamics Inc (ANGO) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

PeopleCEOs, investors, public officials and market commentators.SEC FilingsAuditor changes, restatements, departures and results, from 8-Ks.Insider BuyingCluster buys, and chief executives buying their own stock.The InsidersOne page per filer: every company they file against.